John L. Villano, Md, Phd

This study tested a combination of two immunotherapy drugs (durvalumab and tremelimumab) in 14 adults with advanced solid tumors that had a high number of genetic mutations. The goal was to see if this treatment could slow cancer growth compared to their prior therapy. Participan…

This study tested whether giving a short course of radiation to one tumor site within two weeks of starting immunotherapy could help the immune system fight cancer better. It included 76 people with advanced lung or head/neck cancers who were already eligible for standard immunot…